| DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs H Guo, JA Vuille, BS Wittner, EM Lachtara, Y Hou, M Lin, T Zhao, ... Cell 186 (13), 2765-2782. e28, 2023 | 21 | 2023 |
| Transcriptional activation of Jun and Fos members of the AP‐1 complex is a conserved signature of immune aging that contributes to inflammaging EO Karakaslar, N Katiyar, M Hasham, A Youn, S Sharma, C Chung, ... Aging Cell 22 (4), e13792, 2023 | 18 | 2023 |
| The RNA m5C modification in R-loops as an off switch of Alt-NHEJ H Yang, EM Lachtara, X Ran, J Hopkins, PS Patel, X Zhu, Y Xiao, ... Nature Communications 14 (1), 6114, 2023 | 8 | 2023 |
| Combining chemoproteomics with machine learning identifies functionally active covalent fragments for hard-to-drug cancer drivers JC Hermann, R Everley, L Marholz, M Berberich, TY Yang, YH Chao, ... Cancer Research 83 (7_Supplement), 5333-5333, 2023 | | 2023 |
| Abstract P1-07-05: Gene expression analysis of HOXB13-high and -low tumors reveals a dichotomous immune landscape E Lachtara, M Lawrence, D Sgroi Cancer Research 82 (4_Supplement), P1-07-05-P1-07-05, 2022 | | 2022 |
